Online Impact
Statistics from Altmetric.com
ARTICLE USAGE
Cited By
Article Information
Volume 13, Issue 9, pp. 795-802
PubMed
Published By
Print ISSN
Online ISSN
History
- Received February 27, 2020
- Revision received April 1, 2020
- Accepted June 2, 2020
- Published first June 8, 2020.
Article Versions
- Previous version (June 8, 2020 - 09:10).
- Previous version (August 17, 2020 - 08:36).
- You are viewing the most recent version of this article.
Copyright & Usage
©2020 American Association for Cancer Research.
Author Information
- Soley Bayraktar1,2,
- Sema Baghaki2,
- Jimin Wu3,
- Diane D. Liu3,
- Angelica M. Gutierrez-Barrera2,
- Therese B. Bevers4,
- Vicente Valero2,
- Nour Sneige5, and
- Banu K. Arun2,*
- 1Division of Medical Oncology and Hematology, Department of Medicine, Biruni University School of Medicine, Istanbul, Turkey.
- 2Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
- 3Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas.
- 4Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, Texas.
- 5Department of Cytopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
- ↵*Corresponding Author:
Banu K. Arun, University of Texas MD Anderson Cancer Center, Box 1354, 1155 Pressler Street CPB 5. 3548, Houston, TX 77030. Phone: 713-792-2817; Fax: 171-3563-0910; E-mail: barun{at}mdanderson.org
September 2020
Volume 13, Issue 9
Volume 13, Issue 9
Biomarker Modulation Study of Celecoxib for Chemoprevention in Women at Increased Risk for Breast Cancer: A Phase II Pilot Study
Jump to section
Advertisement